Premium
Assessment of the Safety of Regular D DAVP Therapy in Primary Nocturnal Enuresis
Author(s) -
REW D. A.,
RUNDLE J. S. H.
Publication year - 1989
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1989.tb05215.x
Subject(s) - enuresis , nocturnal , pediatrics , medicine , refractory (planetary science) , biology , astrobiology
Summary— —A group of 7 patients with refractory primary nocturnal enuresis on long‐term DDAVP therapy (mean 13 months) were submitted to a standard water deprivation test in conjunction with a hormone profile and routine haematological and biochemical investigations. No abnormalities were demonstrated, which suggests that the drug is safe in this clinical situation.